Edition:
United States

Zoetis Inc (ZTS.N)

ZTS.N on New York Stock Exchange

75.76USD
2:09pm EST
Change (% chg)

$0.37 (+0.49%)
Prev Close
$75.39
Open
$76.01
Day's High
$76.38
Day's Low
$75.25
Volume
238,600
Avg. Vol
625,560
52-wk High
$76.38
52-wk Low
$52.01

Chart for

About

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock)... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $36,736.66
Shares Outstanding(Mil.): 487.29
Dividend: 0.13
Yield (%): 0.67

Financials

  Industry Sector
P/E (TTM): -- 32.81 16.63
EPS (TTM): -- -- --
ROI: -- 14.96 33.78
ROE: -- 16.51 17.31

BRIEF-Zoetis Says Preliminarily Estimated Reduction To Gaap Net Income In Q4

* ZOETIS SAYS EVALUATING IMPACT OF U.S. TAX ACT, PRELIMINARILY ESTIMATED REDUCTION TO GAAP NET INCOME IN Q4 Source text: (http://bit.ly/2qDYvyf) Further company coverage:

Jan 08 2018

BRIEF-Zoetis Launches Vanguard CIV H3N2/H3N8 Vaccine For Canine Influenza Virus

* ZOETIS LAUNCHES VANGUARD CIV H3N2/H3N8 VACCINE FOR CANINE INFLUENZA VIRUS Source text for Eikon: Further company coverage:

Dec 12 2017

BRIEF-Zoetis Board Approves 20% Dividend Increase

* ZOETIS DECLARES FIRST QUARTER 2018 DIVIDEND; BOARD APPROVES 20% PAYMENT INCREASE

Dec 11 2017

BRIEF-Zoetis Inc Q3 earnings per share $0.61

* Q3 earnings per share view $0.62 -- Thomson Reuters I/B/E/S

Nov 02 2017

BRIEF-Zoetis announces pricing of $1.25 bln of senior notes

* Zoetis Inc - ‍agreed to sell $1.25 billion of senior notes, consisting of $750 million aggregate principal amount of 3.000% senior notes due 2027​

Sep 05 2017

BRIEF-Immunovaccine announces achievement of milestones in collaboration with Zoetis to develop veterinary vaccines

* Immunovaccine announces achievement of milestones in collaboration with Zoetis to develop veterinary vaccines Source text for Eikon: Further company coverage:

Aug 31 2017

BRIEF-Anatara and Zoetis to negotiate terms of an international Detach commercial agreement

* Anatara and Zoetis to negotiate terms of an international Detach® commercial agreement Source text for Eikon: Further company coverage:

Aug 21 2017

BRIEF-Zoetis reports Q2 earnings per share $0.50

* Q2 earnings per share view $0.53 -- Thomson Reuters I/B/E/S

Aug 08 2017

BRIEF-High Court of Ireland approves acquisition of Nexvet by Zoetis Inc's unit

* High Court of Ireland has approved acquisition of Nexvet by Zoetis Inc through its unit Source text for Eikon: Further company coverage:

Jul 28 2017

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $62.56 +3.90
Bayer AG (BAYGn.DE) €104.52 +0.02
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €73.40 +0.20
Eli Lilly and Co (LLY.N) $85.28 -1.70

Earnings vs. Estimates